mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients.
Jennie H KwonMark W TenfordeManjusha GaglaniH Keipp TalbotAdit A GindeTresa McNealShekhar A GhamandeDavid J DouinJonathan D CaseyNicholas M MohrAnne ZepeskiNathan I ShapiroKevin W GibbsD Clark FilesDavid N HagerArber ShehuMatthew E PrekkerSean D CaspersMatthew C ExlineMena BotrosMichelle N GongAlex LiAmira MohamedNicholas J JohnsonVasisht SrinivasanJay S SteingrubIthan D PeltanSamuel M BrownEmily T MartinAkram KhanCatherine L HoughLaurence W BusseAbhijit DuggalJennifer G WilsonCynthia PerezSteven Y ChangChristopher MallowRandal RovinskiHilary M BabcockAdam S LauringLaura FelleyNatasha HalasaJames D ChappellCarlos G GrijalvaTodd W RiceKelsey N WomackChristopher J LindsellKimberly W HartAdrienne BaughmanSamantha M OlsonStephanie SchragMiwako KobayashiJennifer R VeraniManish M PatelWesley H SelfPublished in: The Journal of infectious diseases (2022)
Effectiveness of COVID-19 mRNA vaccines was lower for SOT recipients than immunocompetent adults and those with other immunocompromising conditions. Among SOT recipients, vaccination with 3 doses of an mRNA vaccine led to substantially greater protection than 2 doses.